|
| Crosstalk of parkin and Ret in dopaminergic neurons |
|
https://doi.org/10.18632/oncotarget.4465
Edgar R. Kramer
|
| 15704-15705 |
|
| IP3 3kinase B prevents bone marrow failure |
|
https://doi.org/10.18632/oncotarget.4480
Stephanie Rigaud, and Karsten Sauer
|
| 15706-15707 |
|
| Networking in metabolism and human disease |
|
https://doi.org/10.18632/oncotarget.4561
Leif Väremo, and Jens Nielsen
|
| 15708-15709 |
|
| MEL18 a tumor suppressor for aggressive breast cancer |
|
https://doi.org/10.18632/oncotarget.4565
Jeong-Yeon Lee, and Gu Kong
|
| 15710-15711 |
|
| IER3 in pancreatic carcinogenesis |
|
https://doi.org/10.18632/oncotarget.4588
Maria Inés Molejon, and Juan Lucio Iovanna
|
| 15712-15713 |
|
| Sexual selection and cancer biology |
|
https://doi.org/10.18632/oncotarget.4592
Joshua B. Rubin
|
| 15714-15715 |
|
| Radiation holidays stimulate tumor immunity |
|
https://doi.org/10.18632/oncotarget.4608
Laura Surace, Matthias Guckenberger, and Maries van den Broek
|
| 15716-15717 |
|
| Ubiquitin signals the demise of AMPA receptors |
|
https://doi.org/10.18632/oncotarget.4645
Jocelyn Widagdo, and Victor Anggono
|
| 15718-15719 |
|
| KLF 6: a mitochondrial regulator in the kidney |
|
https://doi.org/10.18632/oncotarget.4647
Sandeep K. Mallipattu, and John C. He
|
| 15720-15721 |
|
| Unleashing rapamycin in fibrosis |
|
https://doi.org/10.18632/oncotarget.4652
Alexander T. Hillel, and Alexander Gelbard
|
| 15722-15723 |
|
| Angiogenesis and bleeding disorders in FNAIT |
|
https://doi.org/10.18632/oncotarget.4757
Issaka Yougbare, Darko Zdravic, and Heyu Ni
|
| 15724-15725 |
|
| Holding it together: Naa60 at the Golgi |
|
https://doi.org/10.18632/oncotarget.4779
Henriette Aksnes, Michaël Marie, and Thomas Arnesen
|
| 15726-15727 |
|
| Astrocytic TGFβ1: detrimental factor in ALS |
|
https://doi.org/10.18632/oncotarget.4786
Fumito Endo, and Koji Yamanaka
|
| 15728-15729 |
|
| Repair of chromosomal breaks by NHEJ |
|
https://doi.org/10.18632/oncotarget.4593
Dylan A. Reid, and Eli Rothenberg
|
| 15730-15731 |
|
| Healed by our inner fish |
|
https://doi.org/10.18632/oncotarget.4594
Philipp Niethammer
|
| 15732-15733 |
|
| SUMO in the DNA damage response |
|
https://doi.org/10.18632/oncotarget.4605
Ivo A. Hendriks, and Alfred C.O. Vertegaal
|
| 15734-15735 |
|
| Gatekeepers of pancreas: TEAD and YAP |
|
https://doi.org/10.18632/oncotarget.4607
Santiago A. RodrÃguez-SeguÃ, and José Bessa
|
| 15736-15737 |
|
| GWAS reveal novel IgA nephropathy risk loci |
|
https://doi.org/10.18632/oncotarget.4632
Jia Nee Foo, Jianjun Liu, and Xue-Qing Yu
|
| 15738-15739 |
|
| Bidirectional talk between AhR and Oct4 |
|
https://doi.org/10.18632/oncotarget.4633
Bo Kang, and Ying-Jie Wang
|
| 15740-15741 |
|
| Vimentin gets a new glow from zinc |
|
https://doi.org/10.18632/oncotarget.4649
Dolores Pérez-Sala, Clara L. Oeste, and Francisco J. Sánchez-Gómez
|
| 15742-15743 |
|
| N6methyladenine: a potential epigenetic mark in eukaryotes |
|
https://doi.org/10.18632/oncotarget.4684
Shoujun Huang, and Dahua Chen
|
| 15744-15745 |
|
| A nuclear sensor of mitochondrial function |
|
https://doi.org/10.18632/oncotarget.4687
Richard M. Monaghan, Gino B. Poulin, and Alan J. Whitmarsh
|
| 15746-15747 |
|
| Plant immune receptor decoy: Pathogens in their own trap |
|
https://doi.org/10.18632/oncotarget.4717
Alice Delga, Clémentine Le Roux, and Laurent Deslandes
|
| 15748-15749 |
|
| Reproductive aging and MCM8/9 |
|
https://doi.org/10.18632/oncotarget.4589
Svetlana A. Yatsenko, and Aleksandar Rajkovic
|
| 15750-15751 |
|
| Hematopoietic cell kinase HCK as a therapeutic target in immune and cancer cells |
|
https://doi.org/10.18632/oncotarget.4199
Ashleigh R. Poh, Robert J.J. O’Donoghue, and Matthias Ernst
|
| 15752-15771 |
|
| Oncogenic cancer/testis antigens: prime candidates for immunotherapy |
|
https://doi.org/10.18632/oncotarget.4694
Morten F. Gjerstorff, Mads H. Andersen, and Henrik J. Ditzel
|
| 15772-15787 |
|
| Selective impact of CDK4/6 suppression on patientderived models of pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.3819
Agnieszka K. Witkiewicz, Nicholas A. Borja, Jorge Franco, Jonathan R. Brody, Charles J. Yeo, John Mansour, Michael A. Choti, Peter McCue, and Erik S. Knudsen
|
| 15788-15801 |
|
| p53 and rapamycin are additive |
|
https://doi.org/10.18632/oncotarget.4602
Barbara Christy, Marco Demaria, Judith Campisi, Jing Huang, Diane Jones, Sherry G. Dodds, Charnae Williams, Gene Hubbard, Carolina B. Livi, Xiaoli Gao, Susan Weintraub, Tyler Curiel, Z. Dave Sharp, and Paul Hasty
|
| 15802-15813 |
|
| A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.4538
Irene Ischenko, Oleksi Petrenko, and Michael J. Hayman
|
| 15814-15827 |
|
| TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney |
|
https://doi.org/10.18632/oncotarget.4682
Saskia L. Gooskens, Samantha Gadd, Jaime M. Guidry Auvil, Daniela S. Gerhard, Javed Khan, Rajesh Patidar, Daoud Meerzaman, Qing-Rong Chen, Chih Hao Hsu, Chunhua Yan, Cu Nguyen, Ying Hu, Charles G. Mullighan, Jing Ma, Lawrence J. Jennings, Ronald R. de Krijge, Marry M. van den Heuvel-Eibrink, Malcolm A. Smith, Nicole Ross, Julie M. Gastier-Foster, and Elizabeth J. Perlman
|
| 15828-15841 |
|
| p53 directly activates cystatin D/CST5 to mediate mesenchymalepithelial transition: a possible link to tumor suppression by vitamin D3 |
|
https://doi.org/10.18632/oncotarget.4683
Sabine Hünten, and Heiko Hermeking
|
| 15842-15856 |
|
| Structurally diverse cMyc inhibitors share a common mechanism of action involving ATP depletion |
|
https://doi.org/10.18632/oncotarget.4327
Huabo Wang, Lokendra Sharma, Jie Lu, Paul Finch, Steven Fletcher, and Edward V. Prochownik
|
| 15857-15870 |
|
| Molecular–genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort |
|
https://doi.org/10.18632/oncotarget.3869
Saeko Hayashi, Hikaru Sasaki, Tokuhiro Kimura, Takayuki Abe, Takumi Nakamura, Yohei Kitamura, Tomoru Miwa, Kaori Kameyama, Yuichi Hirose, and Kazunari Yoshida
|
| 15871-15881 |
|
| Histone modifications change with age dietary restriction and rapamycin treatment in mouse brain |
|
https://doi.org/10.18632/oncotarget.4137
Huan Gong, Hong Qian, Robin Ertl, Clinton M. Astle, Gang G. Wang, David E. Harrison, and Xiangru Xu
|
| 15882-15890 |
|
| Hypermaintenance and hypofunction of aged spermatogonia: insight from agerelated increase of Plzf expression |
|
https://doi.org/10.18632/oncotarget.4045
Ianina C. Ferder, and Ning Wang
|
| 15891-15901 |
|
| The effects of graded levels of calorie restriction: I impact of short term calorie and protein restriction on body composition in the C57BL/6 mouse |
|
https://doi.org/10.18632/oncotarget.4142
Sharon E. Mitchell, Zhanhui Tang, Celine Kerbois, Camille Delville, Penelope Konstantopedos, Aurélie Bruel, Davina Derous, Cara Green, Richard M. Aspden, Simon R. Goodyear, Luonan Chen, Jackie J.D. Han, Yingchun Wang, Daniel E.L. Promislow, David Lusseau, Alex Douglas, and John R. Speakman
|
| 15902-15930 |
|
| CpG oligodeoxynucleotide CpG685 upregulates functional interleukin21 receptor on chronic lymphocytic leukemia B cells through an NFκB mediated pathway |
|
https://doi.org/10.18632/oncotarget.3285
Rebekah L. Browning, Xiaokui Mo, Natarajan Muthusamy, and John C. Byrd
|
| 15931-15939 |
|
| Macrolide analog F806 suppresses esophageal squamous cell carcinoma ESCC by blocking β1 integrin activation |
|
https://doi.org/10.18632/oncotarget.3612
Li-Yan Li, Hong Jiang, Yang-Min Xie, Lian-Di Liao, Hui-Hui Cao, Xiu-E Xu, Bo Chen, Fa-Min Zeng, Ying-Li Zhang, Ze-Peng Du, Hong Chen, Wei Huang, Wei Jia, Wei Zheng, Jian-Jun Xie, En-Min Li, and Li-Yan Xu
|
| 15940-15952 |
|
| Pregnancy associated plasma proteinA links pregnancy and melanoma progression by promoting cellular migration and invasion |
|
https://doi.org/10.18632/oncotarget.3643
Prashanth Prithviraj, Matthew Anaka, Sonja J. McKeown, Michael Permezel, Marzena Walkiewicz, Jonathan Cebon, Andreas Behren, and Aparna Jayachandran
|
| 15953-15965 |
|
| Vimentin contributes to epithelialmesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation |
|
https://doi.org/10.18632/oncotarget.3862
Ching-Yi Liu, Hsi-Hui Lin, Ming-Jer Tang, and Yang-Kao Wang
|
| 15966-15983 |
|
| Radiationinduced microRNA622 causes radioresistance in colorectal cancer cells by downregulating Rb |
|
https://doi.org/10.18632/oncotarget.3762
Wenhui Ma, Jiang Yu, Xiaolong Qi, Li Liang, Yan Zhang, Yi Ding, Xiaoshan Lin, Guoxin Li, and Yanqing Ding
|
| 15984-15994 |
|
| miR504 mediated downregulation of nuclear respiratory factor 1 leads to radioresistance in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.4138
Luqing Zhao, Min Tang, Zheyu Hu, Bin Yan, Weiwei Pi, Zhi Li, Jing Zhang, Liqin Zhang, Wuzhong Jiang, Guo Li, Yuanzheng Qiu, Fang Hu, Feng Liu, Jingchen Lu, Xue Chen, Lanbo Xiao, Zhijie Xu, Yongguang Tao, Lifang Yang, Ann M. Bode, Zigang Dong, Jian Zhou, Jia Fan, Lunquan Sun, and Ya Cao
|
| 15995-16018 |
|
| Deficiency of caspase 3 in tumor xenograft impairs therapeutic effect of measles virus Edmoston strain |
|
https://doi.org/10.18632/oncotarget.3496
Biao Wang, Xu Yan, Qingguo Guo, Yan Li, Haiyan Zhang, JiSheng Xie, and Xin Meng
|
| 16019-16030 |
|
| Tanshinone I inhibits tumor angiogenesis by reducing STAT3 phosphorylation at TYR705 and hypoxiainduced HIF1α accumulation in both endothelial and tumor cells |
|
https://doi.org/10.18632/oncotarget.3648
Yan Wang, Jia-Xin Li, Ying-Qing Wang, and Ze-Hong Miao
|
| 16031-16042 |
|
| MicroRNA155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1 |
|
https://doi.org/10.18632/oncotarget.3755
Yang Peng, Wen Dong, Tian-xin Lin, Guang-zheng Zhong, Bei Liao, Bo Wang, Peng Gu, Li Huang, Yun Xie, Fu-ding Lu, Xu Chen, Wei-bin Xie, Wang He, Shao-xu Wu, and Jian Huang
|
| 16043-16058 |
|
| Correlation between tumor engraftment in patientderived xenograft models and clinical outcomes in colorectal cancer patients |
|
https://doi.org/10.18632/oncotarget.3863
Bo Young Oh, Woo Yong Lee, Sungwon Jung, Hye Kyung Hong, Do-Hyun Nam, Yoon Ah Park, Jung Wook Huh, Seong Hyeon Yun, Hee Cheol Kim, Ho-Kyung Chun, and Yong Beom Cho
|
| 16059-16068 |
|
| Ca2+/calmodulindependent protein kinase IIγ enhances stemlike traits and tumorigenicity of lung cancer cells |
|
https://doi.org/10.18632/oncotarget.3866
Shoujie Chai, Xia Xu, Yongfang Wang, You Zhou, Chenchen Zhang, Yiming Yang, Ying Yang, Haiyan Xu, Rongzhen Xu, and Kai Wang
|
| 16069-16083 |
|
| Novel cross talk between IGFIR and DDR1 regulates IGFIR trafficking signaling and biological responses |
|
https://doi.org/10.18632/oncotarget.3177
Roberta Malaguarnera, Maria Luisa Nicolosi, Antonella Sacco, Alaide Morcavallo, Veronica Vella, Concetta Voci, Michela Spatuzza, Shi-Qiong Xu, Renato V. Iozzo, Riccardo Vigneri, Andrea Morrione, and Antonino Belfiore
|
| 16084-16105 |
|
| Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas |
|
https://doi.org/10.18632/oncotarget.3867
Tao Fang, Meiling Cui, Ji Sun, Chao Ge, Fangyu Zhao, Lin Zhang, Hua Tian, Lixing Zhang, Taoyang Chen, Guoping Jiang, Haiyang Xie, Ying Cui, Ming Yao, Hong Li, and Jinjun Li
|
| 16106-16119 |
|
| Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP13 production |
|
https://doi.org/10.18632/oncotarget.3878
Yingchao Fan, Yu Gan, Yuling Shen, Xiaojin Cai, Yanfang Song, Fangyu Zhao, Ming Yao, Jianren Gu, and Hong Tu
|
| 16120-16134 |
|
| Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome |
|
https://doi.org/10.18632/oncotarget.3873
Damien A. Leach, Eleanor F. Need, Roxanne Toivanen, Andrew P. Trotta, Helen M. Palenthorpe, David J. Tamblyn, Tina Kopsaftis, Georgina M. England, Eric Smith, Paul A. Drew, Carole B. Pinnock, Peng Lee, Jeff Holst, Gail P. Risbridger, Samarth Chopra, Donald B. DeFranco, Renea A. Taylor, and Grant Buchanan
|
| 16135-16150 |
|
| Recombinant human alpha fetoprotein synergistically potentiates the anticancer effects of 1’S1’acetoxychavicol acetate when used as a complex against human tumours harbouring AFPreceptors |
|
https://doi.org/10.18632/oncotarget.3951
Norhafiza M. Arshad, Lionel L.A. In, Tchen Lin Soh, Mohamad Nurul Azmi, Halijah Ibrahim, Khalijah Awang, Elena Dudich, Eduard Tatulov, and Noor Hasima Nagoor
|
| 16151-16167 |
|
| Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer |
|
https://doi.org/10.18632/oncotarget.3753
Dan Li, Xiang Zhao, Yong Xiao, Hong Mei, Jiarui Pu, Xuan Xiang, Wanju Jiao, Huajie Song, Hongxia Qu, Kai Huang, Liduan Zheng, and Qiangsong Tong
|
| 16168-16182 |
|
| Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells |
|
https://doi.org/10.18632/oncotarget.3952
Mikaella Vouri, Qian An, Matthew Birt, Geoffrey J. Pilkington, and Sassan Hafizi
|
| 16183-16197 |
|
| Lactate promotes PGE2 synthesis and gluconeogenesis in monocytes to benefit the growth of inflammationassociated colorectal tumor |
|
https://doi.org/10.18632/oncotarget.3838
Libin Wei, Yuxin Zhou, Jing Yao, Chen Qiao, Ting Ni, Ruichen Guo, Qinglong Guo, and Na Lu
|
| 16198-16214 |
|
| MET expression and copy number heterogeneity in nonsquamous nonsmall cell lung cancer nsNSCLC |
|
https://doi.org/10.18632/oncotarget.3976
David Casadevall, Javier Gimeno, Sergi Clavé, Ãlvaro Taus, Lara Pijuan, Miriam ArumÃ, Marta Lorenzo, Silvia Menéndez, Israel Cañadas, Joan Albanell, Sergio Serrano, Blanca Espinet, Marta Salido, and Edurne Arriola
|
| 16215-16226 |
|
| miR15b5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma both in vitro and in vivo by suppressing Rab1A |
|
https://doi.org/10.18632/oncotarget.3970
Yang Yang, Ni Hou, Xiaofei Wang, Lumin Wang, Su’e Chang, Kang He, Zhenghao Zhao, Xiaoge Zhao, Tusheng Song, and Chen Huang
|
| 16227-16238 |
|
| ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer |
|
https://doi.org/10.18632/oncotarget.3842
Feng Zhang, Xutao Zhang, Jin Meng, Yong Zhao, Xinli Liu, Yanxia Liu, Yukun Wang, Yuhua Li, Yang Sun, Zhipeng Wang, Qibing Mei, and Tao Zhang
|
| 16239-16252 |
|
| Hepatomaderived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis |
|
https://doi.org/10.18632/oncotarget.3608
San-Cher Chen, Tsung-Hui Hu, Chao-Cheng Huang, Mei-Lang Kung, Tian-Huei Chu, Li-Na Yi, Shih-Tsung Huang, Hoi-Hung Chan, Jiin-Haur Chuang, Li-Feng Liu, Han-Chung Wu, Deng-Chyang Wu, Min-Chi Chang, and Ming-Hong Tai
|
| 16253-16270 |
|
| Phosphorylation of interleukin IL24 is required for mediating its anticancer activity |
|
https://doi.org/10.18632/oncotarget.3977
Janani Panneerselvam, Manish Shanker, Jiankang Jin, Cynthia D. Branch, Ranganayaki Muralidharan, Yan D. Zhao, Sunil Chada, Anupama Munshi, and Rajagopal Ramesh
|
| 16271-16286 |
|
| Ubiquitin Cterminal hydrolaseL1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4 |
|
https://doi.org/10.18632/oncotarget.3843
Hyun Jung Kim, Venkataraman Magesh, Jae-Jin Lee, Sun Kim, Ulla G. Knaus, and Kong-Joo Lee
|
| 16287-16303 |
|
| Vitamin D3dependent VDR signaling delays ronmediated breast tumorigenesis through suppression of βcatenin activity |
|
https://doi.org/10.18632/oncotarget.4059
Abby L. Johnson, Glendon M. Zinser, and Susan E. Waltz
|
| 16304-16320 |
|
| Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation migration and invasion |
|
https://doi.org/10.18632/oncotarget.3872
Wen-Liang Chen, Andrew Barszczyk, Ekaterina Turlova, Marielle Deurloo, Baosong Liu, Burton B. Yang, James T. Rutka, Zhong-Ping Feng, and Hong-Shuo Sun
|
| 16321-16340 |
|
| Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.3854
Shinichiro Fukuhara, Inik Chang, Yozo Mitsui, Takeshi Chiyomaru, Soichiro Yamamura, Shahana Majid, Sharanjot Saini, Guoren Deng, Ankurpreet Gill, Darryn K. Wong, Hiroaki Shiina, Norio Nonomura, Yun-Fai C. Lau, Rajvir Dahiya, and Yuichiro Tanaka
|
| 16341-16351 |
|
| Loss of RAB1B promotes triplenegative breast cancer metastasis by activating TGFβ/SMAD signaling |
|
https://doi.org/10.18632/oncotarget.3877
Hong-Lin Jiang, He-Fen Sun, Shui-Ping Gao, Liang-Dong Li, Xin Hu, Jiong Wu, and Wei Jin
|
| 16352-16365 |
|
| PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest |
|
https://doi.org/10.18632/oncotarget.3879
Li Huang, Yang Peng, Guangzheng Zhong, Weibin Xie, Wen Dong, Bo Wang, Xu Chen, Peng Gu, Wang He, Shaoxu Wu, Tianxin Lin, and Jian Huang
|
| 16366-16378 |
|
| Polyphenolrich extract of Pimenta dioica berries Allspice kills breast cancer cells by autophagy and delays growth of triple negative breast cancer in athymic mice |
|
https://doi.org/10.18632/oncotarget.3834
Lei Zhang, Nagarajarao Shamaladevi, Guddadarangavvanahally K. Jayaprakasha, Bhimu S. Patil, and Bal L. Lokeshwar
|
| 16379-16395 |
|
| Honokiol abrogates leptininduced tumor progression by inhibiting Wnt1MTA1βcatenin signaling axis in a microRNA34a dependent manner |
|
https://doi.org/10.18632/oncotarget.3844
Dimiter B. Avtanski, Arumugam Nagalingam, Panjamurthy Kuppusamy, Michael Y. Bonner, Jack L. Arbiser, Neeraj K. Saxena, and Dipali Sharma
|
| 16396-16410 |
|
| Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer |
|
https://doi.org/10.18632/oncotarget.3845
Shu Xia, Manish Kohli, Meijun Du, Rachel L. Dittmar, Adam Lee, Debashis Nandy, Tiezheng Yuan, Yongchen Guo, Yuan Wang, Michael R. Tschannen, Elizabeth Worthey, Howard Jacob, William See, Deepak Kilari, Xuexia Wang, Raymond L. Hovey, Chiang-Ching Huang, and Liang Wang
|
| 16411-16421 |
|
| Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling |
|
https://doi.org/10.18632/oncotarget.3847
Qiu-Yan He, Hong-Mei Yi, Hong Yi, Ta Xiao, Jia-Quan Qu, Li Yuan, Jin-Feng Zhu, Jiao-Yang Li, Yuan-Yuan Wang, Li-Na Li, Juan Feng, Shan-Shan Lu, and Zhi-Qiang Xiao
|
| 16422-16436 |
|
| Accumulation of ALDH1positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.4103
Tiyasha H. Ayub, Mignon-Denise Keyver-Paik, Manuel Debald, Babak Rostamzadeh, Thore Thiesler, Lars Schröder, Winfried Barchet, Alina Abramian, Christina Kaiser, Glen Kristiansen, Walther Kuhn, and Kirsten Kübler
|
| 16437-16448 |
|
| SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: wholegenome analysis in patients with hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3758
Yeon-Su Lee, Bo Hyun Kim, Byung Chul Kim, Aesun Shin, Jin Sook Kim, Seung-Hyun Hong, Jung Ah Hwang, Jung Ahn Lee, Seungyoon Nam, Sung Hoon Lee, Jong Bhak, and Joong-Won Park
|
| 16449-16460 |
|
| By recruiting HDAC1 MORC2 suppresses p21 Waf1/Cip1 in gastric cancer |
|
https://doi.org/10.18632/oncotarget.3889
Qing Zhang, Yanyan Song, Wei Chen, Xiaohui Wang, Zhifeng Miao, Liu Cao, Feng Li, and Guiling Wang
|
| 16461-16470 |
|
| Neutrophils trigger a NFκB dependent polarization of tumorsupportive stromal cells in germinal center Bcell lymphomas |
|
https://doi.org/10.18632/oncotarget.4106
Murielle Grégoire, Fabien Guilloton, Céline Pangault, Frédéric Mourcin, Phaktra Sok, Maelle Latour, Patricia Amé-Thomas, Erwan Flecher, Thierry Fest, and Karin Tarte
|
| 16471-16487 |
|
| Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells |
|
https://doi.org/10.18632/oncotarget.4108
Marijke C.C. Sachweh, William C. Stafford, Catherine J. Drummond, Anna R. McCarthy, Maureen Higgins, Johanna Campbell, Bertha Brodin, Elias S.J. Arnér, and Sonia LaÃn
|
| 16488-16506 |
|
| Nuclear EGFR impairs ASPP2p53 complexinduced apoptosis by inducing SOS1 expression in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3757
Kai Liu, Tao Jiang, Yabo Ouyang, Ying Shi, Yunjin Zang, Ning Li, Shichun Lu, and Dexi Chen
|
| 16507-16516 |
|
| Increased cathepsin D protein expression is a biomarker for osteosarcomas pulmonary metastases and other bone malignancies |
|
https://doi.org/10.18632/oncotarget.4140
Timo Gemoll, Franziska Epping, Lisa Heinrich, Britta Fritzsche, Uwe J. Roblick, Silke Szymczak, Sonja Hartwig, Reinhard Depping, Hans-Peter Bruch, Christoph Thorns, Stefan Lehr, Andreas Paech, and Jens K. Habermann
|
| 16517-16526 |
|
| A six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.4113
Jin Wang, Jian-Qing Mi, Alexandra Debernardi, Anne-Laure Vitte, Anouk Emadali, Julia A. Meyer, Konstantina Charmpi, Bernard Ycart, Mary B. Callanan, William L. Carroll, Saadi Khochbin, and Sophie Rousseaux
|
| 16527-16542 |
|
| ATRX represses alternative lengthening of telomeres |
|
https://doi.org/10.18632/oncotarget.3846
Christine E. Napier, Lily I. Huschtscha, Adam Harvey, Kylie Bower, Jane R. Noble, Eric A. Hendrickson, and Roger R. Reddel
|
| 16543-16558 |
|
| Notch signaling sustains the expression of Mcl1 and the activity of eIF4E to promote cell survival in CLL |
|
https://doi.org/10.18632/oncotarget.4116
Filomena De Falco, Rita Sabatini, Beatrice Del Papa, Franca Falzetti, Mauro Di Ianni, Paolo Sportoletti, Stefano Baldoni, Isabella Screpanti, Pierfrancesco Marconi, and Emanuela Rosati
|
| 16559-16572 |
|
| Estrogenic gper signaling regulates mir144 expression in cancer cells and cancerassociated fibroblasts cafs |
|
https://doi.org/10.18632/oncotarget.4117
Adele Vivacqua, Paola De Marco, Maria Francesca Santolla, Francesca Cirillo, Michele Pellegrino, Maria Luisa Panno, Sergio Abonante, and Marcello Maggiolini
|
| 16573-16587 |
|
| Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion |
|
https://doi.org/10.18632/oncotarget.3752
Minh Phuong Nguyen, Dongjin Lee, Se-Hyung Lee, Hye-Eun Lee, Ho-Young Lee, and You Mie Lee
|
| 16588-16600 |
|
| 111Incetuximab as a diagnostic agent by accessible epidermal growth factor EGF receptor targeting in human metastatic colorectal carcinoma |
|
https://doi.org/10.18632/oncotarget.3968
Ying-Hsia Shih, Cheng-Liang Peng, Shin-Yu Lee, Ping-Fang Chiang, Cheng-Jung Yao, Wuu-Jyh Lin, Tsai-Yueh Luo, and Ming-Jium Shieh
|
| 16601-16610 |
|
| ERG deregulation induces IGF1R expression in prostate cancer cells and affects sensitivity to antiIGF1R agents |
|
https://doi.org/10.18632/oncotarget.3425
Caterina Mancarella, Irene Casanova-Salas, Ana Calatrava, Selena Ventura, Cecilia Garofalo, José Rubio-Briones, Vera Magistroni, Maria Cristina Manara, José Antonio López-Guerrero, and Katia Scotlandi
|
| 16611-16622 |
|
| Mcl1 is an important therapeutic target for oral squamous cell carcinomas |
|
https://doi.org/10.18632/oncotarget.3932
Santanu Maji, Sabindra K. Samal, Laxmipriya Pattanaik, Swagatika Panda, Bridget A. Quinn, Swadesh K. Das, Devanand Sarkar, Maurizio Pellecchia, Paul B. Fisher, and Rupesh Dash
|
| 16623-16637 |
|
| Dual regulation by microRNA200b3p and microRNA200b5p in the inhibition of epithelialtomesenchymal transition in triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.3184
Lyndsay V. Rhodes, Elizabeth C. Martin, H. Chris Segar, David F. B. Miller, Aaron Buechlein, Douglas B. Rusch, Kenneth P. Nephew, Matthew E. Burow, and Bridgette M. Collins-Burow
|
| 16638-16652 |
|
| Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patients |
|
https://doi.org/10.18632/oncotarget.3914
Hyun Ae Jung, Chi Hoon Maeng, Moonjin Kim, Sungmin Kim, Chul Won Jung, and Jun Ho Jang
|
| 16653-16662 |
|
| TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma |
|
https://doi.org/10.18632/oncotarget.4389
Mohamed Ali Mosrati, Annika Malmström, Malgorzata Lysiak, Adam Krysztofiak, Martin Hallbeck, Peter Milos, Anna-Lotta Hallbeck, Charlotte Bratthäll, Michael Strandéus, Marie Stenmark-Askmalm, and Peter Söderkvist
|
| 16663-16673 |
|
| Longitudinal study on circulating miRNAs in patients after lung cancer resection |
|
https://doi.org/10.18632/oncotarget.4322
Petra Leidinger, Valentina Galata, Christina Backes, Cord Stähler, Stefanie Rheinheimer, Hanno Huwer, Eckart Meese, and Andreas Keller
|
| 16674-16685 |
|
| Difference between observed and expected number of involved lymph nodes reflects the metastatic potential of breast cancer independent to intrinsic subtype |
|
https://doi.org/10.18632/oncotarget.3647
Ke-Da Yu, Yi-Zhou Jiang, and Zhi-Ming Shao
|
| 16686-16697 |
|
| An openlabel singlearm phase I/II study of lowerdose decitabine based therapy in patients with advanced hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3677
Qian Mei, Meixia Chen, Xuechun Lu, Xiang Li, Feng Duan, Maoqiang Wang, Guangbin Luo, and Weidong Han
|
| 16698-16711 |
|
| Immunohistochemical and genomic profiles of diffuse large Bcell lymphomas: Implications for targeted EZH2 inhibitor therapy |
|
https://doi.org/10.18632/oncotarget.3154
Sydney Dubois, Sylvain Mareschal, Jean-Michel Picquenot, Pierre-Julien Viailly, Elodie Bohers, Marie Cornic, Philippe Bertrand, Elena Liana Veresezan, Philippe Ruminy, Catherine Maingonnat, Vinciane Marchand, Hélène Lanic, Dominique Penther, Christian Bastard, Hervé Tilly, and Fabrice Jardin
|
| 16712-16724 |
|
| Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases |
|
https://doi.org/10.18632/oncotarget.4264
Shuimei Luo, Long Chen, Xiuping Chen, and Xianhe Xie
|
| 16725-16734 |
|
| Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort |
|
https://doi.org/10.18632/oncotarget.3793
Kwan-Hwa Chi, Hui-Ling Ko, Kai-Lin Yang, Cheng-Yen Lee, Mau-Shin Chi, and Shang-Jyh Kao
|
| 16735-16745 |
|
| Activation of insulinlike growth factor 1 receptor in patients with nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.3796
Jin-Soo Kim, Edward S. Kim, Diane Liu, J. Jack Lee, Carmen Behrens, Scott M. Lippman, Waun Ki Hong, Ignacio I. Wistuba, Euni Lee, and Ho-Young Lee
|
| 16746-16756 |
|
| Six stromabased RNA markers diagnostic for prostate cancer in EuropeanAmericans validated at the RNA and protein levels in patients in China |
|
https://doi.org/10.18632/oncotarget.4430
Jianguo Zhu, Cong Pan, Jun Jiang, Mingsen Deng, Hengjun Gao, Bozhao Men, Michael McClelland, Dan Mercola, Wei-De Zhong, and Zhenyu Jia
|
| 16757-16765 |
|
| Distinctive clinical characteristics of malignant mesothelioma in young patients |
|
https://doi.org/10.18632/oncotarget.4414
Anish Thomas, Yuanbin Chen, Tinghui Yu, Ammara Gill, and Vinay Prasad
|
| 16766-16773 |
|
| Highthroughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin |
|
https://doi.org/10.18632/oncotarget.3736
Moubin Lin, Yajie Zhang, Ajian Li, Erjiang Tang, Jian Peng, Wenxian Tang, Yong Zhang, Liang Lu, Yihua Xiao, Qing Wei, Lu Yin, and Huaguang Li
|
| 16774-16785 |
